- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Apr 30, 2026 | 25.91M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 25.94M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 25.91M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 25.88M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 25.86M sh |
| Dividends Paid | Q2 2026 · Mar 31, 2026 | $4.14M |
| Dividends Paid | Q2 2026 · Mar 31, 2025 | $4.13M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2026 | $75.28M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2025 | $58.28M |
| Long Term Debt | Q2 2026 · Mar 31, 2026 | $125M |
| Long Term Debt | Q2 2026 · Sep 30, 2025 | $166M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2026 | $92.25M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $101.35M |
| Stockholders Equity | Q2 2026 · Mar 31, 2026 | $1.59B |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $1.54B |
| Stockholders Equity | Q2 2026 · Mar 31, 2025 | $1.28B |
| Current Liabilities | Q2 2026 · Mar 31, 2026 | $500.37M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $508.15M |
| Total Liabilities | Q2 2026 · Mar 31, 2026 | $820.39M |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $869.52M |
| Current Assets | Q2 2026 · Mar 31, 2026 | $726.79M |
| Current Assets | Q2 2026 · Sep 30, 2025 | $688.51M |
| Total Assets | Q2 2026 · Mar 31, 2026 | $2.41B |
| Total Assets | Q2 2026 · Sep 30, 2025 | $2.41B |
| Total Assets restated | Q2 2026 · Mar 31, 2025 | $1.7B |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $1.34 |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $2.45 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $1.20 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $2.11 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $1.34 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $2.45 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $1.20 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $2.11 |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $62.83M |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $124.04M |
| Sga Expense restated | Q2 2026 · Mar 31, 2025 | $54.29M |
| Sga Expense restated | Q2 2026 · Mar 31, 2025 | $109.26M |
| Net Income | Q2 2026 · Mar 31, 2026 | $34.73M |
| Net Income | Q2 2026 · Mar 31, 2026 | $63.42M |
| Net Income | Q2 2026 · Mar 31, 2025 | $31.03M |
| Net Income | Q2 2026 · Mar 31, 2025 | $54.51M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $178.03M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $347.77M |
| Cost Of Revenue restated | Q2 2026 · Mar 31, 2025 | $132.5M |
| Cost Of Revenue restated | Q2 2026 · Mar 31, 2025 | $256.72M |
| Revenue | Q2 2026 · Mar 31, 2026 | $309.34M |
| Revenue | Q2 2026 · Mar 31, 2026 | $599M |
| Revenue restated | Q2 2026 · Mar 31, 2025 | $231.78M |
| Revenue restated | Q2 2026 · Mar 31, 2025 | $446.37M |